Treating Vitiligo
According to a press release by Incyte, The U.S. Food and Drug Administration has granted approval for a topical treatment for vitiligo in patients 12 and older. The Delaware-based pharmaceutical company announced on Monday that its Opzelura cream, known as Ruxolitinib, is the first FDA-approved treatment for repigmentation in patients with nonsegmental vitiligo, the most…
Read More